http://www.unboundmedicine.com/medline/ebm/research/glimepirideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19891554/full_citation/Presence_of_CYP2C9_3_allele_increases_risk_for_hypoglycemia_in_Type_2_diabetic_patients_treated_with_sulfonylureas_Ragia G, Petridis I, Tavridou A, et al. 
Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas. [Journal Article]
Pharmacogenomics 2009 Nov; 10(11):1781-7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19873688/full_citation/A_simulation_of_the_comparative_long_term_effectiveness_of_liraglutide_and_glimepiride_monotherapies_in_patients_with_type_2_diabetes_mellitus_Sullivan SD, Alfonso-Cristancho R, Conner C, et al. 
A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus. [Journal Article]
Pharmacotherapy 2009 Nov; 29(11):1280-8.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19821654/full_citation/Once_daily_initiation_with_biphasic_insulin_aspart_30_versus_insulin_glargine_in_patients_with_type_2_diabetes_inadequately_controlled_with_oral_drugs:_an_open_label_multinational_RCT_Strojek K, Bebakar WM, Khutsoane DT, et al. 
Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Oct 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19800638/full_citation/Glimepiride_induces_proliferation_and_differentiation_of_rat_osteoblasts_via_the_PI3_kinase/Akt_pathway_Ma P, Gu B, Ma J, et al. 
Glimepiride induces proliferation and differentiation of rat osteoblasts via the PI3-kinase/Akt pathway. [JOURNAL ARTICLE]
Metabolism 2009 Oct 1.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19799532/full_citation/Influence_of_genetic_polymorphisms_on_the_pharmacokinetics_and_pharmaco_dynamics_of_sulfonylurea_drugs_Xu H, Murray M, McLachlan AJ 
Influence of genetic polymorphisms on the pharmacokinetics and pharmaco-dynamics of sulfonylurea drugs. [Journal Article]
Curr Drug Metab 2009 Jul; 10(6):643-58.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19796836/full_citation/Glibenclamide_related_excess_in_total_and_cardiovascular_mortality_risks:_Data_from_large_Ukrainian_observational_cohort_study_Khalangot M, Tronko M, Kravchenko V, et al. 
Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study. [JOURNAL ARTICLE]
Diabetes Res Clin Pract 2009 Sep 29.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19765654/full_citation/Triple_verses_Glimepiride_plus_Metformin_therapy_on_Cardiovascular_Risk_Biomarkers_and_Diabetic_Cardiomyopathy_in_Insulin_Resistance_Type_2_Diabetes_Mellitus_Rats_Sharma AK, Srinivasan BP 
Triple verses Glimepiride plus Metformin therapy on Cardiovascular Risk Biomarkers and Diabetic-Cardiomyopathy in Insulin Resistance Type 2 Diabetes Mellitus Rats. [JOURNAL ARTICLE]
Eur J Pharm Sci 2009 Sep 15.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19758357/full_citation/The_European_Exenatide_study_of_long_term_exenatide_vs__glimepiride_for_type_2_diabetes:_rationale_and_patient_characteristics_Kazda C, Gallwitz B, Simó R, et al. 
The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics. [JOURNAL ARTICLE]
Diabetes Obes Metab 2009 Sep 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19747013/full_citation/Liraglutide:_a_review_of_its_use_in_type_2_diabetes_mellitus_Croom KF, McCormack PL 
Liraglutide: a review of its use in type 2 diabetes mellitus. [Journal Article]
Drugs 2009; 69(14):1985-2004.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19744248/full_citation/CHICAGO_PERISCOPE_and_PROactive:_CV_risk_modification_in_diabetes_with_pioglitazone_John Betteridge D 
CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone. [JOURNAL ARTICLE]
Fundam Clin Pharmacol 2009 Sep 10.
Abstract | Full Citation